Filing Details
- Accession Number:
- 0001209191-13-013896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-05 16:08:25
- Reporting Period:
- 2013-03-01
- Filing Date:
- 2013-03-05
- Accepted Time:
- 2013-03-05 16:08:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1528831 | N Kristine Tatsutani | 4698 Willow Road Suite 100 Pleasanton CA 94588 | Cso, Svp Of Reg., Clinic & Qa | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-01 | 2,700 | $2.83 | 34,548 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-01 | 2,700 | $4.68 | 31,848 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-03-01 | 2,700 | $0.00 | 2,700 | $2.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,125 | 2021-05-17 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2012.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $4.95 inclusive. The reporting person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- 25% of the granted 117,696 shares became exercisable on 5/18/12. The remaining shares vest in a series of 36 equal monthly installments, provided the Reporting Person continues to provide service to ZELTIQ Aesthetics, Inc.
Billionaire Hedge Funds
